glp 1 based therapy GLP-1 therapy's potential in treating heart, brain, and liver diseases beyond diabetes GLP-1 Drugs: Bridging Satiety, Nutrition,

However, this result is expected considering the very high activity of glutaredoxins as deglutathionylating enzymes and a decreased GSSR concentration neither excludes mechanism (ii) or (iii) from Fig

Mol Aspects Med 34(23):516528 Angelini C, Vergani L, Martinuzzi A (1992) Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of b-oxidation

Pseudomonas aeruginosa breaches respiratory epithelia through goblet cell invasion in a microtissue model

Effects of GLP-1 receptor agonists on incident gynecologic cancer outcomes in endometriosis patients compared to metformin: a real-world cohort